Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry

Clinical Chemistry

Volumn 48, Issue 9, 2002, Pages 1615-1618

  Skopp, Gisela ^a   Pötsch, Lucia ^a   Mattern, Rainer ^a   Aderjan, Rolf ^a  

^a Institute of Legal Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 3 HYDROXYLYSERGIC ACID DIETHYLAMIDE; LYSERGIDE; N NORLYSERGIC ACID DIETHYLAMIDE; PSYCHEDELIC AGENT; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; DRUG STABILITY; DRUG URINE LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 0036720953     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.9.1615     Document Type: Article

References (25)

1. Stability of drugs of abuse in biological specimens
2. Analysis of LSD in urine using radioimmunoassay - Excretion and storage effects
3. Effective GC-MS procedure for detecting iso-LSD in urine after base-catalyzed conversion to LSD
4. Quantification of LSD and N-desmethyl-LSD in urine by gas chromatography/resonance electron capture ionization mass spectrometry
5. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid phase extraction and gas-chromatography-tandem mass spectrometry
6. Determination of lysergic acid diethylamide (LSD), iso-LSD, and N-demethyl-LSD in body fluids by gas chromatography/tandem mass spectrometry
7. Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens
8. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens; 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD
9. Detection of lysergic acid diethylamide (LSD) in urine by gas chromatography-ion trap tandem mass spectrometry
10. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood
11. Automated extraction of lysergic acid diethylamide (LSD) and n-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation
12. On-line immunoaffinity extraction-coupled column capillary liquid chromatography/tandem mass spectrometry: Trace analysis of LSD analogs and metabolites in human urine
13. Determination of LSD and N-demethyl-LSD in urine by liquid chromatography coupled to electrospray ionization mass spectrometry
14. Interference with testing for lysergic acid diethylamide
15. False-positive LSD drug screening induced by a mucolytic medication
16. Indirect enzyme-linked immunosorbent assay for the quantitative estimation of lysergic acid diethylamide in urine
17. The analysis of lysergide (LSD): The development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure
18. Determination of LSD in urine by capillary column gas chromatography and electron impact mass spectrometry
19. Stability study of LSD under various storage conditions
20. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit
21. Estimating shelf-life of drugs in solution
22. New synthesis and characterization of (+)-lysergic acid diethylamide (LSD) derivatives and the development of a microparticle-based immunoassay for the detection of LSD and its metabolites